Hengbin Gao

Hengbin Gao serves as a Research Associate within the UWA Medical School and the UWA Centre for Medical Research, an institution affiliated with the Harry Perkins Institute of Medical Research at The University of Western Australia in Perth. His academic profile indicates active contributions to research in two distinct but molecularly-focused fields: plant reproductive biology and cancer genetics. Based in Australia, Dr. Gao collaborates internationally, as evidenced by multi-institutional publications in high-impact journals including Nature Plants and Frontiers of Medicine.

Dr. Gao's primary research interests encompass Cancer Biology, Molecular Genetics, Plant Development, and Transcriptional Regulation. His work in cancer biology centers on the HOXB13 gene, examining its role in carcinogenesis, drug resistance mechanisms, and clinical oncology implications. In plant biology, he investigates the molecular control of female germline development in cereals, particularly through MADS-box transcription factors like MADS31 that repress post-fertilization programmes in ovules. These dual research streams demonstrate expertise in genetic and epigenetic regulation across biological kingdoms.

Analysis of his 2025 publications reveals complementary research trajectories: the plant biology work addresses fundamental seed development mechanisms with potential agricultural applications for food security, while the cancer biology research explores molecular pathways in malignancy with therapeutic relevance. Both domains contribute significantly to UN Sustainable Development Goals 2 (Zero Hunger) and 3 (Good Health and Well-being), reflecting translational impact from basic science to global challenges.

No scientific awards or honors were documented in the available profile information.

Details regarding graduate student supervision, grant funding portfolios, or leadership of research teams were not disclosed in the provided materials.

Hengbin Gao operates within the UWA Centre for Medical Research ecosystem, which forms part of the Harry Perkins Institute of Medical Research—a premier Australian medical research institution focused on advancing disease understanding and improving health outcomes through innovative translational research.